How to make sure you and a new doctor are on the same page about how to treat your Type 1 diabetes.
Federal regulators declare the CGM just as good as fingersticks in making blood sugar management decisions.
A look back at the breakthroughs…and the debate over the name.
A certified diabetes educator provides 13 tips.
Medical caregivers are warned that the practice can lead to misdosing.
Spending on diabetes care takes up a significant slice of the GDP, and that slice will only get bigger.
Advocates cited insulin prices as a major reason for why the measure was needed.
How to get the most out of your doctor visits and stay as safe as possible in the hospital.
A nurse is on trial for refusing to treat a woman with Type 1 in jail until it was too late.
A certified diabetes educator provides suggestions for what to do about it.
The Department of Justice and the FTC are asked to investigate whether Lilly, Novo Nordisk, and Sanofi colluded to raise prices.
A woman with Type 1 describes the bizarre-sounding gear she used as a child.
The petition has been led by a member of Parliament who has Type 1 diabetes.
An analysis of the candidate’s drug-pricing plan and what it would take to make it work.
Some in the Type 1 diabetes community wonder whether the term is accurate, and whether it’s accurate for the Medtronic 670G.
JDRF chief mission officer Dr. Aaron Kowalski says we don’t yet have the tools for a fully automated artificial pancreas.
An argument that it’s different enough and automated enough to warrant the title.
The Medtronic 670G will be sold commercially in the spring of 2017.
There was a problem with the needles.
With the move, the drug company seemingly declares to go down with the Lantus ship.